Mediating effect analysis of visceral adiposity index on free triiodothyronine to free thyroxine ratio and non-alcoholic fatty liver disease in euthyroid population

被引:0
|
作者
Liu, Huan-Xin [1 ]
Ren, Yan-Yan [2 ]
Meng, Cui-Qiao [1 ]
Li, Zhong [3 ]
Nie, Qian [1 ]
Yu, Chun-Hong [1 ]
Ma, Hui-Juan [4 ,5 ]
机构
[1] Hebei Gen Hosp, Hlth Examinat Ctr, Shijiazhuang, Peoples R China
[2] Hebei Gen Hosp, Dept Neurol, Shijiazhuang, Peoples R China
[3] Shijiazhuang peoples Hosp, Dept Gen Surg, Shijiazhuang, Peoples R China
[4] Hebei Gen Hosp, Key Lab Metab Dis Hebei Prov, Shijiazhuang, Peoples R China
[5] Hebei Gen Hosp, Dept Endocrinol, Shijiazhuang, Peoples R China
来源
关键词
visceral adiposity index; free triiodothyronine to free thyroxine ratio; non-alcoholic fatty liver disease; thyroid function; mediating effect; METABOLIC PARAMETERS; INSULIN-RESISTANCE; THYROID-HORMONES; PREDICTOR;
D O I
10.3389/fendo.2022.961803
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThe association between free triiodothyronine/free thyroxine (FT3/FT4) and non-alcoholic fatty liver disease (NAFLD) in euthyroid subjects is unclear. In addition, few studies have explored whether VAI mediates the association between FT3/FT4 ratio and NAFLD in the euthyroid population. We aimed to analyze the mediating effect of VAI on the FT3/FT4 ratio and NAFLD risk in the euthyroid population. MethodsThis cross-sectional study included 7 946 annual health examinees from the Health Examination Center, Hebei General Hospital, from January to December 2020. The basic information and biochemical parameters, as well as calculated FT3/FT4 ratio and VAI were collected. NAFLD was diagnosed according to abdominal ultrasonography. The fibrosis score for NAFLD positive subjects (NFS) was calculated to reflect the extent of liver fibrosis. The risk of NAFLD was analyzed by quartiles of FT3/FT4 ratio (Q1-Q4 quartiles) and VAI (V1-V4 quartiles), respectively. Pearson correlation analysis was performed to investigate the correlation between FT3/FT4 ratio and VAI. Multivariate logistic regression analysis was applied to analyze the effect of FT3/FT4 ratio and VAI on NAFLD and NFS status. Bootstrap was conducted to explore whether VAI mediated the association between FT3/FT4 ratio and NAFLD. ResultsOf the 7 946 participants, 2 810 (35.36%) had NAFLD and 5 136 (64.64%) did not. Pearson correlation analysis indicated that FT3/FT4 ratio was positively associated with VAI (P<0.05). Multivariate logistic regression analysis indicated that compared to the Q1 group, the risk of NAFLD significantly increased in Q3 group [OR=1.255, 95%CI (1.011, 1.559)] and Q4 group [OR=1.553, 95%CI (1.252, 1.926)](P<0.05). Compared to the V1 group, the risk of NAFLD notably increased in V2 group [OR=1.584, 95%CI (1.205, 2.083)], V3 group [OR=2.386, 95%CI (1.778, 3.202)] and V4 group [OR=4.104, 95%CI (2.835, 5.939)] (P<0.01). There was no relevance between FT3/FT4 ratio, VAI and NFS status. Mediating effect analysis showed that FT3/FT4 ratio significantly directly influenced NAFLD prevalence [beta=3.7029, 95%CI (2.9583, 4.4474)], and VAI partly mediated the indirect effect of the FT3/FT4 ratio on NAFLD prevalence [beta=2.7649, 95%CI (2.2347, 3.3466)], and the mediating effect accounted for 42.75% of the total effects. ConclusionBoth FT3/FT4 ratio and VAI were predictors of NAFLD, and VAI partly mediated the indirect effect of the FT3/FT4 ratio on NAFLD prevalence in the euthyroid population.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Effect of resveratrol on non-alcoholic fatty liver disease
    Theodotou, Marios
    Fokianos, Konstantinos
    Moniatis, Demetris
    Kadlenic, Rudolf
    Chrysikou, Asimina
    Aristotelous, Andrea
    Mouzouridou, Alexia
    Diakides, John
    Stavrou, Eliza
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (01) : 559 - 565
  • [42] Fatty Liver Index (FLI) in Predicting Non-alcoholic Fatty Liver Disease (NAFLD)
    Dehnavi, Zahra
    Razmpour, Farkhonde
    Naseri, Mahmoud Belghaisi
    Nematy, Mohsen
    Alamdaran, Seyed Ali
    Vatanparast, Hassan Ali
    Nezhad, Mohsen Azimi
    Abbasi, Bita
    Ganji, Azita
    HEPATITIS MONTHLY, 2018, 18 (02)
  • [43] Non-alcoholic Fatty Liver Disease in a Jamaican Patient Population
    King-Robinson, K.
    Lee, M. G.
    Whittle, D.
    Mills, M.
    Hanchard, B.
    Shah, S.
    WEST INDIAN MEDICAL JOURNAL, 2016, 65 (03): : 557 - 560
  • [44] MicroRNAs in the Liver and Visceral Adipose Tissue in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Soronen, Jarkko
    Perttila, Julia
    Yki-Jarvinen, Hannele
    Olk-Konen, Vesa
    DIABETES, 2012, 61 : A43 - A44
  • [45] Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease
    Jeong Woo Kim
    Young-Sun Lee
    Yang Shin Park
    Baek-Hui Kim
    Soo Yeon Lee
    Jong Eun Yeon
    Chang Hee Lee
    Scientific Reports, 10
  • [46] Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease
    Kim, Jeong Woo
    Lee, Young-Sun
    Park, Yang Shin
    Kim, Baek-Hui
    Lee, Soo Yeon
    Yeon, Jong Eun
    Lee, Chang Hee
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [47] Visceral fat and non-alcoholic fatty liver disease: is there an association? (a preliminary report)
    Red-Oliver, Eji Nadine
    Payawal, Diana A.
    Sy, Rosa Allyn
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A36 - A36
  • [48] ZJU index: A novel model for predicting non-alcoholic fatty liver disease in a Chinese population
    Wang, Jinghua
    Xu, Chengfu
    Xun, Yunhao
    Lu, Zhenya
    Yu, Chaohui
    Li, Youming
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 327 - 327
  • [49] Low serum total thyroxine and free triiodothyronine in patients with hepatic encephalopathy due to non-alcoholic cirrhosis
    Kayacetin, E
    Kisakol, G
    Kaya, A
    SWISS MEDICAL WEEKLY, 2003, 133 (13-14) : 210 - 213
  • [50] Liver stiffness measurement to platelet ratio index predicts the stage of liver fibrosis in non-alcoholic fatty liver disease
    Okajima, Akira
    Sumida, Yoshio
    Taketani, Hiroyoshi
    Hara, Tasuku
    Seko, Yuya
    Ishiba, Hiroshi
    Nishimura, Takeshi
    Umemura, Atsushi
    Nishikawa, Taichiro
    Yamaguchi, Kanji
    Moriguchi, Michihisa
    Mitsuyoshi, Hironori
    Yasui, Kohichiroh
    Minami, Masahito
    Itoh, Yoshito
    HEPATOLOGY RESEARCH, 2017, 47 (08) : 721 - 730